Medical Equipment

Implantable Infusion Pumps Market Revenue Expected to Reach $28.24 Billion by 2030 with 6.8% CAGR

March 12, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Implantable Infusion Pumps Market From 2026 To 2030?

The implantable infusion pumps market has experienced robust expansion in recent years. It is projected to expand from $20.32 billion in 2025 to $21.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.9%. Historically, this growth can be ascribed to factors such as the increasing prevalence of chronic pain conditions, a rising incidence of diabetes, an increase in oncology treatment procedures, technological advancements in implantable pumps, and the broadening of specialty clinical care.

The implantable infusion pumps market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $28.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is fueled by several factors, including the rising adoption of intelligent infusion technologies, a greater need for remote patient observation, the broadening of tailored dosing regimens, increased capital allocated to digital therapeutics, and the expanded deployment of implantable pumps in homecare environments. Key trends expected during this period encompass the wider embrace of programmable infusion devices, a surge in demand for enduring pain management options, the increasing utilization of smart and networked pumps, the growth of implantable insulin delivery systems, and a heightened emphasis on precise dosage.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3347&type=smp

What Key Drivers Are Influencing The Growth Of The Implantable Infusion Pumps Market?

The expanding older demographic is anticipated to propel the growth of the implantable infusion pumps market in the future. This aging population is defined as the proportion of individuals 65 and older compared to the employed population between the ages of 18 and 64. The increase in this demographic results from enhanced life expectancy, a consequence of advancements in healthcare and living standards, leading to more individuals living longer. Implantable infusion pumps are commonly utilized for managing chronic conditions, meaning that a larger aging population creates a broader pool of potential patients who stand to benefit from these devices. For example, in February 2025, Eurostat, the Luxembourg statistical office of the European Union, reported that the European Union’s estimated population in 2024 was approximately 449 million people, with over one-fifth, or 21.6%, being 65 years and over, and a median age of 44.7 years. The old-age dependency ratio in the EU climbed by half a percentage point (0.5 pp) between 2023 and 2024, rising from 33.4% to 33.9%. Thus, the growth in the aging population is a primary factor driving the expansion of the implantable infusion pumps market.

Which Segments Are Included In The Analysis Of The Implantable Infusion Pumps Market?

The implantable infusion pumps market covered in this report is segmented –

1) By Type: Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Other Types

2) By Applications: Oncology, Pediatrics Or Neonatology, Gastroenterology, Hematology, Diabetes, Other Applications

3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Subsegments:

1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps, Fentanyl PCA Pumps, Other Opioid PCA Pumps

2) By Enteral Pumps: Tube Feeding Pumps, Syringe-based Enteral Pumps, Continuous Or Intermittent Feeding Pumps

3) By Insulin Pumps: Insulin Delivery Pumps, Insulin Patch Pumps, Smart Insulin Pumps

4) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps

5) By Syringe Pumps: Small Volume Syringe Pumps, Large Volume Syringe Pumps

6) By Other Types: Chemotherapy Infusion Pumps, Antibiotic Infusion Pumps, Pain Management Pumps

Which Trends Are Impacting The Growth Of The Implantable Infusion Pumps Market?

Leading firms within the implantable infusion pumps market are introducing innovative products like insulin pumps, aiming to expand their customer reach, boost sales volumes, and enhance their financial returns. These insulin pumps serve as medical instruments specifically engineered to support individuals living with diabetes in regulating their blood glucose concentrations. An example of this innovation occurred in April 2023, when Medtronic, a medical device manufacturer based in Ireland, revealed that its MiniMed 780G System, featuring meal detection technology, had received FDA approval. A key characteristic of this particular product is its capacity to establish the lowest glucose target, specifically 100 mg/dL, among all automated insulin pumps currently offered, thereby mirroring the typical glucose readings found in non-diabetic individuals. This configuration allows the pump to function on a treat-to-target principle, performing automatic adjustments to basal insulin and self-corrections to achieve a predefined goal. Furthermore, it is unique as the sole pump featuring an infusion set designed for comfortable extended wear, lasting for a duration of up to 7 days. This prolonged usage is facilitated by sophisticated materials that significantly reduce the degradation of insulin preservatives and ensure a steady insulin delivery and stability, consequently lessening the likelihood of the infusion set becoming blocked.

Which Key Industry Participants Are Active In The Implantable Infusion Pumps Market?

Major companies operating in the implantable infusion pumps market are Medtronic plc, Boston Scientific Corporation, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.

Read the full implantable infusion pumps market report here:

https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Implantable Infusion Pumps Market?

North America was the largest region in the implantable infusion pumps market in 2025. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Implantable Infusion Pumps Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3347&type=smp

Browse Through More Reports Similar to the Global Implantable Infusion Pumps Market 2026, By The Business Research Company

Infusion Pump Market Report 2026

https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report

Ambulatory Iv Infusion Pumps Market Report 2026

https://www.thebusinessresearchcompany.com/report/ambulatory-iv-infusion-pumps-global-market-report

Intravenous Infusion Pumps Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795